Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of warrant activity

v3.22.1
Stockholders' Deficit (Details) - Schedule of warrant activity - Warrant [Member]
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Warrant Number of Shares outstanding at beginning | shares 9,258,191
Warrant Weighted Average Exercise Price outstanding at beginning | $ / shares $ 0.45
Warrant Weighted Average Remaining Contractual Term outstanding at beginning 6 years 10 months 6 days
Warrant Aggregate Intrinsic Value outstanding at beginning | $ $ 304,799
Granted Number of Shares | shares
Granted Weighted Average Exercise Price | $ / shares
Granted Weighted Average Remaining Contractual Term
Granted Aggregate Intrinsic Value | $
Forfeited Number of Shares | shares
Forfeited Weighted Average Exercise Price | $ / shares
Forfeited Weighted Average Remaining Contractual Term
Forfeited Aggregate Intrinsic Value | $
Exercised Number of Shares | shares
Exercised Weighted Average Exercise Price | $ / shares
Exercised Weighted Average Remaining Contractual Term
Exercised Aggregate Intrinsic Value | $
Expired Number of Shares | shares
Expired Weighted Average Exercise Price | $ / shares
Expired Weighted Average Remaining Contractual Term
Expired Aggregate Intrinsic Value | $
Warrant Number of Shares outstanding at ending | shares 9,258,191
Warrant Weighted Average Exercise Price outstanding at ending | $ / shares $ 0.45
Warrant Weighted Average Remaining Contractual Term outstanding at ending 6 years 7 months 9 days
Warrant Aggregate Intrinsic Value outstanding at ending | $ $ 548,780
Warrant Number of Shares exercisable at ending | shares 7,758,191
Warrant Weighted Average Exercise Price exercisable at ending | $ / shares $ 0.38
Warrant Weighted Average Remaining Contractual Term exercisable at ending 7 years 10 months 17 days
Warrant Aggregate Intrinsic Value exercisable at ending | $ $ 548,780